US Corporate Board Director Changes SEC Filings — June 11, 2026

USA Board Room Changes

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

The June 11, 2026, filing set reveals a significant wave of leadership transitions across US-listed companies, with a notable concentration of CEO successions (Compass Diversified, Mohawk Industries, Brady Corp, Alaska Silver, Duke Robotics) and CFO changes (Marvell Technology, DENTSPLY SIRONA, Nukkleus).

A key theme is the high level of shareholder dissent at annual meetings, with several companies (Yext, Inogen, Legence Corp, Veracyte) seeing over 20% votes against directors or compensation plans, signaling governance concerns. The most critical development is Weatherford International's failed redomestication from Ireland to the US, which fell short of the required 75% shareholder support despite majority approval, creating strategic uncertainty. Additionally, Fulcrum Therapeutics' severe restructuring (downsizing to 9 employees) and Regenerex Pharma's lawsuit against its former CFO for alleged fraud highlight acute operational and governance risks. Portfolio-level patterns include a trend of appointing directors with AI and defense expertise (PennyMac, Duke Robotics) and a wave of insider departures without cause (Elvictor Group, Callan JMB).

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from June 04, 2026.

Investment Signals (10)

  • Appointed Dan Durn (ex-Adobe, Applied Materials CFO) as CFO effective June 15, 2026, signaling a commitment to financial discipline and semiconductor leadership. Durn's deep industry experience and the reaffirmed Q2 FY2027 outlook suggest stability.

  • CEO transition to Vineet Nargolwala (ex-Allegro MicroSystems CEO) is tied to the pending acquisition of Honeywell's PSS business, which Nargolwala helped evaluate as a board member. This suggests a strategic, well-planned succession to drive M&A integration.

  • Appointed AI expert Tiffany To to the board, aligning with its tech-first mortgage strategy. The company reported strong operational metrics ($154B in new loans, $720B serviced), indicating a focus on AI-driven efficiency gains.

  • Appointed Yiftach Kleinman, a defense industry veteran who led SpearUAV's acquisition, as CEO. This signals a strategic push to expand defense business post-Nasdaq uplisting, with a clear catalyst in the growing defense tech sector.

  • Disclosed $406M in treasury holdings including $90M in OpenAI equity and a massive 8.4% of Worldcoin's circulating supply. This unique exposure to AI and digital identity creates a high-risk, high-reward catalyst, especially with OpenAI's confidential S-1 filing.

  • Failed redomestication to the US (despite >60% support) creates strategic overhang. The company intends to present a revised proposal, but the failure signals significant shareholder opposition to the current plan.

  • Severe restructuring (down to 9 employees) after discontinuing its lead pipeline asset (pociredir). Retention payments to executives and enhanced change-in-control benefits suggest a potential sale or wind-down, but the operational viability is in question.

  • Filed a lawsuit against former CFO for alleged fraud ($55K payroll overpayments, $37K self-dealing, unauthorized stock issuance). This indicates material internal control failures and potential regulatory exposure, with the delayed 10-K filing as a red flag.

  • Yext (BEARISH)

    Director Andrew Sheehan received 20.8M votes against (33% of votes cast), the highest dissent in this filing set. The equity plan also saw 14.4M votes against, signaling significant governance concerns among shareholders.

  • Inogen (BEARISH)

    Proposal to declassify the board failed, and director Mira Sahney received a 27.4% withhold vote. This indicates shareholder frustration with the current board structure and governance practices.

Risk Flags (9)

  • The proposed move from Ireland to Texas failed to achieve the required 75% shareholder support, despite >60% approval. This creates strategic uncertainty and may lead to a revised, potentially less favorable proposal.

  • The company reduced its workforce to just 9 full-time employees after discontinuing its lead drug candidate. Retention payments to top executives and enhanced change-in-control benefits suggest a potential sale, but the business is essentially a shell.

  • The lawsuit against former CFO for alleged fraud (unauthorized payroll, self-dealing, stock issuance, record destruction) points to severe internal control weaknesses. The delayed 10-K filing increases the risk of Nasdaq non-compliance or SEC investigation.

  • Director Bilal Khan received 21.0M withhold votes (21.4% of votes cast), a significant level of shareholder opposition. This may indicate concerns about his performance or independence.

  • Yext/Governance Concerns [MODERATE RISK]

    Director Andrew Sheehan faced 33% votes against his election, and the equity plan saw 14.4M votes against. This level of dissent suggests deep shareholder dissatisfaction with board composition and compensation practices.

  • The failure of the board declassification proposal, combined with a 27.4% withhold vote for director Mira Sahney, indicates shareholders are pushing for governance changes that the board is resisting.

  • The removal of Christodoulos Tzoutzakis as COO and CTO without cause, just after appointing a new CTO, suggests internal turmoil or a strategic pivot that may disrupt operations.

  • The filing includes forward-looking statements about submitting a plan to regain compliance with Nasdaq's stockholders' equity requirement within 45 days. Failure to do so could result in delisting.

  • The say-on-pay proposal received 18.5% votes against, and director Michael Paolucci faced 17.8% votes against. This level of dissent, while not controlling, signals growing shareholder unease.

Opportunities (8)

  • Dan Durn's appointment as CFO (effective June 15) brings a proven track record of financial leadership at Adobe, Applied Materials, and NXP. His experience in scaling semiconductor businesses could drive margin expansion and capital allocation improvements.

  • Tiffany To's appointment signals a strategic push into AI-driven mortgage processing. With $154B in new loan production and $720B serviced, even modest efficiency gains from AI could translate into significant margin expansion.

  • The appointment of Yiftach Kleinman, who led SpearUAV's acquisition, as CEO signals a clear strategy to scale the defense business. The recent Nasdaq uplisting provides a platform for capital raising and M&A in the growing defense tech sector.

  • The company's $406M treasury includes $90M in OpenAI equity and 8.4% of Worldcoin's circulating supply. With OpenAI's confidential S-1 filing and Worldcoin's $6.35T addressable market, this is a high-conviction bet on AI and digital identity.

  • The CEO transition to Vineet Nargolwala is directly tied to the pending Honeywell PSS acquisition. Nargolwala's experience evaluating the deal as a board member suggests a smooth integration, potentially unlocking synergies and driving EPS growth.

  • Aaron Schutt, former CEO of a $500M+ revenue enterprise (Doyon Limited), brings deep Alaska-based leadership experience. His appointment as CEO (effective Oct 1) could accelerate the company's drilling campaign in Greenland's Jameson Land Basin.

  • The planned retirement of co-founder Elias Sabo and succession by Zach Sawtelle (who led $3B+ in transactions) provides a clear leadership transition. The reaffirmed FY2026 outlook and review of the Management Services Agreement could unlock shareholder value.

  • Kenneth Escoe, EVP of Specialty Products at Illinois Tool Works, brings deep industrial expertise. His appointment as an independent director could provide valuable operational insights and improve governance.

Sector Themes (6)

  • CEO Succession Wave

    6 companies (Compass Diversified, Mohawk Industries, Brady Corp, Alaska Silver, Duke Robotics, LVPAI Group) announced CEO transitions in this filing set. This concentration suggests a broader leadership renewal cycle, often tied to strategic pivots or M&A activity. Investors should monitor for potential strategy shifts.

  • Shareholder Dissent on Governance

    Multiple companies (Yext, Inogen, Legence Corp, Veracyte, Orthofix) saw >15% votes against directors or compensation plans. This pattern indicates growing shareholder activism and dissatisfaction with board composition, compensation practices, and governance structures.

  • AI and Defense Expertise in Demand

    Board and C-suite appointments increasingly feature AI (PennyMac, Elvictor) and defense (Duke Robotics, Pelican Holdco) expertise. This reflects a strategic shift as companies seek to capitalize on AI-driven efficiency and the growing defense tech sector.

  • Failed Strategic Transactions

    Weatherford's failed redomestication and Fulcrum's pipeline discontinuation highlight execution risks in corporate strategy. These events can create significant value destruction or strategic overhang, requiring close monitoring.

  • Internal Control Failures in Small Caps

    Regenerex Pharma's lawsuit against its former CFO for alleged fraud underscores the heightened risk of internal control failures in smaller, less-established companies. This is a recurring theme in SEC filings and warrants due diligence.

  • Planned vs. Abrupt Leadership Changes

    The filing set shows a mix of well-planned successions (Mohawk, Compass Diversified, Brady Corp) and abrupt departures (Elvictor Group, Callan JMB, Allied Energy). The latter often signals underlying operational or governance issues.

Watch List (8)

  • Failed redomestication proposal; watch for revised proposal details and shareholder reaction. Next meeting likely within 6-12 months.

  • Severe restructuring to 9 employees; watch for M&A activity, wind-down announcements, or further executive departures. Retention payments suggest a potential sale process.

  • Lawsuit against former CFO; watch for SEC investigation, Nasdaq compliance issues, and impact on the delayed 10-K filing. Material internal control weaknesses are a key risk.

  • Dan Durn assumes CFO role on June 15; watch for Q2 FY2027 earnings call (expected late August) for initial commentary on financial strategy and capital allocation.

  • CEO transition effective June 8; watch for updates on the Honeywell PSS acquisition closing and integration progress. Earnings call in August will be key.

  • Yiftach Kleinman expected to start as CEO by September 8; watch for strategic announcements regarding defense contract wins or M&A. The Nasdaq uplisting provides a platform for growth.

  • OpenAI's confidential S-1 filing and potential IPO; watch for updates on the IPO timeline and valuation, which could significantly impact Eightco's $90M OpenAI equity stake.

  • Must submit Nasdaq compliance plan within 45 days (by ~July 26); watch for the plan submission and any updates on regaining compliance with stockholders' equity requirements.

Filing Analyses (50)
SAFE & GREEN HOLDINGS CORP. 8-K neutral materiality 5/10

11-06-2026

Olenox Industries Inc. (formerly Safe & Green Holdings Corp.) appointed Erik Blum as President effective June 1, 2026, with a one-year employment agreement providing a $200,000 annual base salary, a $50,000 restricted stock grant vesting over 18 months, and an annual performance bonus of up to 20% of base salary. Concurrently, the company dismissed CFO Patricia Kaelin on June 5, 2026, and has begun searching for a replacement. The filing does not disclose any financial results or period-over-period comparisons.

  • · Erik Blum has over 30 years of experience in debt, corporate finance, and company management, and previously led FYNN from non-reporting pink sheet status to an audited reporting entity as of November 2023.
  • · Blum resigned from the Audit Committee and as Chair of the Audit Committee prior to his appointment as President.
  • · Blum is subject to a one-year post-termination non-compete and non-solicit, and confidentiality provisions.
  • · Patricia Kaelin was dismissed on June 5, 2026, and the company received her resignation letter the same day.
  • · The company will file any response letter from Kaelin with the SEC within two business days of receipt.
Compass Diversified Holdings 8-K neutral materiality 6/10

11-06-2026

Compass Diversified (CODI) announced that CEO and co-founder Elias Sabo will retire on December 31, 2026, and will be succeeded by Zach Sawtelle, who has been appointed COO and named CEO successor. The company reaffirmed its full-year 2026 outlook with strong subsidiary momentum, while continuing to review its Management Services Agreement to align incentives with shareholders.

  • · CEO Elias Sabo will retire as CEO and a director on December 31, 2026.
  • · Zach Sawtelle appointed COO effective June 11, 2026, and will succeed Sabo as CEO/Board member upon retirement.
  • · Sawtelle joined Compass Group Management in 2009 and led over 20 strategic transactions representing over $3B aggregate value.
  • · Sawtelle chairs BOA and held board roles at PrimaLoft, The Honey Pot, 5.11, and Altor Solutions.
  • · Company reaffirms previously announced 2026 outlook; expects to complete Management Services Agreement review 'in the coming weeks'.
  • · CODI remains focused on reducing leverage, maximizing subsidiary value, and returning capital to shareholders opportunistically.
HALLADOR ENERGY CO 8-K neutral materiality 5/10

11-06-2026

Hallador Energy Company appointed Matthew Bradford White as Chief Legal Officer effective June 8, 2026. Mr. White brings extensive legal and energy industry experience from TransMontaigne Partners, Oracle America, and Morrison & Foerster. The company also disclosed his compensation package, including a $500,000 base salary, performance bonus potential, RSU grants, and change-in-control retention benefits.

  • · Mr. White previously served as Executive Vice President, General Counsel and Secretary of TransMontaigne Partners L.L.C. from September 2021 to present.
  • · The signing bonus RSUs vest immediately but must be returned if Mr. White voluntarily terminates employment within one year or is terminated for cause.
  • · The retention bonus upon change in control includes 2.5 times annualized performance bonus plus prorated bonus for the fiscal year of closing.
  • · Mr. White holds a Juris Doctor from the University of Denver Sturm College of Law, an MBA from Daniels College of Business, and a B.S. in Civil Engineering from West Point.
  • · There are no family relationships between Mr. White and any director or executive officer, and no material interests in transactions requiring disclosure under Item 404(a).
MOHAWK INDUSTRIES INC 8-K neutral materiality 6/10

11-06-2026

Mohawk Industries announced a CEO succession plan: Paul F. De Cock, currently President and COO, will become CEO and a director effective September 30, 2026, succeeding Jeffrey S. Lorberbaum, who will retire as CEO after 25 years but remain Chairman of the Board. The transition reflects a planned leadership change following a 50-year career for Lorberbaum and over two decades of experience for De Cock, with no financial metrics or performance data provided in the filing.

  • · Jeffrey Lorberbaum has served as Chairman since May 2004 and CEO since January 2001.
  • · Paul De Cock joined Mohawk through the acquisition of Unilin in 2005.
  • · De Cock was appointed President and COO in February 2025 as part of the succession planning process.
  • · Mohawk is described as the world's largest flooring manufacturer with leading positions in North America, Europe, South America, and Oceania.
  • · The company's brands include American Olean, Daltile, Durkan, Eliane, Elizabeth, Feltex, Godfrey Hirst, Karastan, Marazzi, Mohawk, Mohawk Group, Pergo, Quick-Step, Unilin, and Vitromex.
Pelican Holdco, Inc. 8-K positive materiality 6/10

11-06-2026

Greenland Energy Company (NASDAQ: GLND) announced the appointment of Carol Craig to its Board of Directors, effective June 5, 2026, filling the vacancy created by Daniel M. McCabe's resignation. Ms. Craig, founder and CEO of Sidus Space, brings extensive aerospace and defense experience and will serve on the Audit Committee. The company is preparing for its first modern onshore drilling campaign in Greenland's Jameson Land Basin, currently planned for 2026.

  • · Ms. Craig was appointed as a Class I director and will serve on the Audit Committee.
  • · She is 59 years old and currently pursuing a Ph.D. in Systems Engineering at Florida Institute of Technology.
  • · Sidus Space completed its IPO on Nasdaq in December 2021 and launched three LizzieSat satellites (LS-1 March 2024, LS-2 December 2024, LS-3 March 2025).
  • · Prior to Sidus Space, Ms. Craig founded Craig Technologies in 1999, an aerospace and defense engineering firm.
  • · She served in the U.S. Navy as a P-3 Orion Naval Flight Officer and was among the first women eligible to fly in combat aircraft.
  • · The Board determined Ms. Craig qualifies as an independent director under Nasdaq rules and meets Audit Committee independence requirements under Rule 10A-3.
  • · Greenland Energy's licensed area in the Jameson Land Basin is approximately 2 million acres onshore.
Orthofix Medical Inc. 8-K mixed materiality 6/10

11-06-2026

Orthofix Medical Inc. held its 2026 Annual Meeting of Shareholders on June 10, 2026, where all director nominees were elected, executive compensation was approved on an advisory basis, Ernst & Young LLP was ratified as independent auditor, and shareholders approved Amendment No. 5 to the Stock Purchase Plan, increasing available shares by 1,250,000. While the advisory vote on executive compensation passed, it received significant opposition with 5,577,200 votes against (18.5% of votes cast), indicating notable shareholder dissent.

  • · Director Michael E. Paolucci received the highest number of votes against among all nominees (5,367,249), representing 17.8% of votes cast.
  • · Director Wayne Burris also faced notable opposition with 5,162,812 votes against (17.2% of votes cast).
  • · The advisory vote on executive compensation had 14,545 abstentions in addition to the 5,577,200 against.
  • · Auditor ratification passed overwhelmingly with 33,262,505 votes in favor (96.0% of votes cast).
  • · The Stock Purchase Plan amendment was approved with 29,235,005 votes in favor (97.2% of votes cast on the matter).
TILLY'S, INC. 8-K positive materiality 6/10

11-06-2026

Tilly's, Inc. held its 2026 annual meeting on June 10, 2026, where stockholders elected seven directors, approved the Fourth Amendment and Restated 2012 Equity and Incentive Award Plan, ratified BDO USA, P.C. as independent auditor, and approved executive compensation on an advisory basis. All proposals passed with strong support, though broker non-votes were significant on most items.

  • · All seven director nominees were elected with votes for ranging from 77,128,473 to 77,326,500, and votes withheld from 2,633,871 to 2,831,898.
  • · Proposal 2 (Plan approval) received 79,220,610 votes for, 739,201 against, and 560 abstentions.
  • · Proposal 3 (auditor ratification) passed with 86,460,798 votes for, 196,042 against, and 8,281 abstentions, with no broker non-votes.
  • · Proposal 4 (advisory say-on-pay) received 78,298,527 votes for, 1,263,128 against, and 398,716 abstentions.
  • · Broker non-votes were 6,704,750 on Proposals 1, 2, and 4, but zero on Proposal 3.
Unicoin Inc. 8-K positive materiality 5/10

11-06-2026

Silvina Moschini resigned as Chief Strategy Officer of Unicoin Inc., effective June 1, 2026, to become Interim CEO of the Unicoin Foundation. The filing highlights a positive regulatory outlook and the company's planned ICO, but no financial metrics or performance data are provided.

  • · Resignation effective June 1, 2026.
  • · Moschini transitions to Interim CEO of the Unicoin Foundation.
  • · Filing references a more constructive regulatory environment and new crypto taxonomy as opportunities.
  • · No financial figures, employee counts, or performance metrics are disclosed in this filing.
KIORA PHARMACEUTICALS INC 8-K mixed materiality 6/10

11-06-2026

Kiora Pharmaceuticals held its 2026 Annual Meeting on June 10, 2026, where shareholders elected three Class II directors (Lisa Walters-Hoffert, Aron Shapiro, and Praveen Tyle, Ph.D.) and approved an amendment to the 2024 Equity Incentive Plan increasing authorized shares by 1,500,000. All proposals received majority support, though broker non-votes on several items were significant, and the equity plan amendment garnered the lowest approval rate among voted shares (approximately 69% for vs. 29% against). The ratification of Haskell & White LLP as independent auditor was overwhelmingly approved with over 99.7% of votes cast in favor.

  • · Broker non-votes totaled 1,320,660 on Proposals 1, 2, and 4, representing about 48% of the outstanding shares.
  • · Lisa Walters-Hoffert received the most votes for among directors with 1,037,950 (99.26% of votes cast excluding broker non-votes).
  • · Praveen Tyle, Ph.D. received the fewest votes for among directors with 1,029,403 (98.45% of votes cast excluding broker non-votes).
  • · Proposal 3 (auditor ratification) had no broker non-votes and passed with overwhelming support.
HYCROFT MINING HOLDING CORP 8-K neutral materiality 4/10

11-06-2026

Hycroft Mining Holding Corp. entered into an employment agreement with Eric B. Colby as Executive Vice President, Corporate Development and Investor Relations, effective June 8, 2026. Mr. Colby brings extensive mining and capital markets experience, including 15 years at Newmont Corporation and most recently as VP Operations at Magris Performance Materials. The agreement provides a base salary of $450,000, an annual cash incentive bonus target of 80% of base salary (0%-200% range), and includes standard termination and change-in-control provisions.

  • · Mr. Colby joined Hycroft in April 2026, prior to the formal employment agreement.
  • · Termination without Cause or for Good Reason entitles Mr. Colby to 1.5x base salary paid over 18 months plus 18 months of continued benefits.
  • · Termination after a Change in Control (within 90 days before or 1 year after) entitles Mr. Colby to 2.0x base salary plus 2.0x the greater of prior year actual bonus, current year actual bonus, or target bonus, paid in a lump sum on day 60, plus 24 months of continued benefits.
  • · The agreement includes standard definitions for Cause, Change in Control, Disability, and Good Reason.
  • · Mr. Colby is an at-will employee and may be terminated at any time for any or no reason.
Allied Energy, Inc. 8-K neutral materiality 3/10

11-06-2026

Allied Energy, Inc. (AGGI) filed an 8-K on June 11, 2026, but the exhibit attached (Ex-99.1) pertains to BILI Social International, Inc.'s Audit Committee Charter, effective June 9, 2026. The filing references Items 5.02, 7.01, 8.01, and 9.01, suggesting potential director/officer changes or other material events, but the provided content only includes the charter. No financial data, officer changes, or other specific events are detailed in the extracted text.

  • · The filing includes Items 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits).
  • · The exhibit is an Audit Committee Charter for BILI Social International, Inc., not directly for Allied Energy, Inc.
  • · No specific officer changes, financial results, or material events are described in the provided content.
CALLAN JMB INC. 8-K neutral materiality 5/10

11-06-2026

On June 5, 2026, Eric Kash resigned as Executive Vice President and Board member of Callan JMB Inc. (CJMB), effective immediately, with no disagreement cited. The company agreed to pay $125,000 in severance (three monthly installments of $41,666.67) plus accrued vacation pay, while Mr. Kash retains 187,500 vested stock options with full 10-year terms. The filing also includes forward-looking statements about Nasdaq compliance, but no financial results or period-over-period comparisons are provided.

  • · Resignation effective June 5, 2026, with no disagreement on operations, policies, or practices.
  • · Settlement Agreement includes mutual releases, termination of Employment Agreement (dated Oct 1, 2024, as amended Oct 24, 2024), and customary confidentiality/non-disparagement clauses.
  • · Forward-looking statements reference intent to submit a plan to regain compliance with Nasdaq Stockholders' Equity Requirement within 45 calendar days.
Yext, Inc. 8-K mixed materiality 6/10

11-06-2026

Yext, Inc. held its annual meeting on June 10, 2026, where stockholders elected two Class III directors (Daniel Englander and Andrew Sheehan), ratified Ernst & Young LLP as auditor for FY ending January 31, 2027, approved executive compensation on an advisory basis, and approved the amended 2016 Equity Incentive Plan. While all proposals passed, the Plan approval saw significant opposition (14.4 million votes against), and director Andrew Sheehan received a substantial 20.8 million votes against his election.

  • · The annual meeting was held on June 10, 2026; record date for voting was April 13, 2026.
  • · Daniel Englander received 61,538,851 votes for and 1,389,188 against; Andrew Sheehan received 42,086,549 for and 20,839,792 against.
  • · Executive compensation (say-on-pay) was approved with 59,780,340 for, 3,163,149 against, and 97,075 abstentions.
  • · The Plan was approved with 48,430,077 for, 14,448,832 against, and 161,655 abstentions.
  • · Ernst & Young LLP was ratified as auditor with 72,769,470 for, 738,784 against, and 360,320 abstentions.
Organon & Co. 8-K mixed materiality 6/10

11-06-2026

Organon & Co. held its 2026 Annual Meeting on June 9, 2026, where stockholders approved an amendment and restatement of the 2021 Incentive Stock Plan, increasing the share reserve by 8,000,000 shares. All ten director nominees were elected, and the advisory vote on executive compensation (say-on-pay) passed with approximately 93.9% of votes cast in favor. However, the say-on-pay proposal received 7,311,933 against votes, indicating some shareholder dissent, and the incentive plan amendment also saw 7,608,906 against votes. The ratification of PricewaterhouseCoopers as auditor was overwhelmingly approved with 196,889,135 votes for.

  • · The annual meeting had 202,635,304 shares present out of 262,600,862 outstanding, a quorum of ~77%.
  • · All ten director nominees were elected with votes for ranging from 143,582,296 (Carrie S. Cox) to 146,867,855 (Ramona Sequeira).
  • · The advisory say-on-pay proposal received 142,593,022 for, 7,311,933 against, and 1,968,636 abstentions.
  • · The incentive plan amendment received 142,473,542 for, 7,608,906 against, and 1,791,143 abstentions.
  • · Auditor ratification received 196,889,135 for, 4,100,954 against, and 1,645,215 abstentions, with no broker non-votes.
  • · Broker non-votes totaled 50,761,713 on all proposals except auditor ratification.
Morgan Stanley Bitcoin Trust 8-K neutral materiality 3/10

11-06-2026

Morgan Stanley Bitcoin Trust filed an 8-K reporting the resignations of directors Ruairi O'Healai (effective June 5, 2026) and Tatiana Segal (effective May 7, 2026) from the Delegated Sponsor. Kaushik Goswami, a Managing Director and former Global Head of Sales & Trading Capital & Funding at Morgan Stanley, was appointed as a director on June 9, 2026, to fill the vacancies. The filing contains no financial results or performance data.

  • · Kaushik Goswami holds a degree in Aerospace Engineering from IIT Bombay and a Masters in Financial Engineering from UC Berkeley.
  • · Goswami began his career in the Equity Derivatives division at Société Générale in Hong Kong.
  • · Goswami has been appointed to the Asset Liability Committee, the ISG Management Committee, and the US Banks Operating Committee.
  • · The trust is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.
UNIVERSAL HEALTH REALTY INCOME TRUST 8-K mixed materiality 5/10

11-06-2026

Universal Health Realty Income Trust (UHT) held its 2026 Annual Meeting on June 10, 2026, where shareholders elected two Class I trustees, approved nonbinding advisory compensation for named executive officers, and ratified KPMG as the independent auditor for FY2026. Additionally, the Compensation Committee granted restricted stock awards to executive officers, including 6,247 shares to CEO Alan B. Miller and 3,631 shares to CFO Charles F. Boyle, with vesting scheduled for the second anniversary. While all proposals passed, a notable 868,560 votes were cast against trustee Robert F. McCadden and 418,954 against executive compensation, indicating some shareholder dissent.

  • · The annual meeting was conducted virtually via live audio webcast.
  • · All three shareholder proposals passed: election of trustees, advisory compensation, and auditor ratification.
  • · CEO Alan B. Miller received 6,247 restricted shares, more than 1.7 times the shares granted to the CFO and SVP Operations (3,631 each).
  • · Robert F. McCadden faced relatively high opposition with 868,560 votes against (9.2%) vs. Alan B. Miller's 222,081 (2.4%).
  • · There were 2,233,065 non-votes for both trustee proposals and the advisory compensation vote, suggesting a significant portion of shares were not voted.
  • · The auditor ratification had zero non-votes, indicating all shares present were voted on that proposal.
Ingredion Inc 8-K positive materiality 4/10

11-06-2026

On June 7, 2026, Ingredion Inc. elected Kenneth Escoe as an independent director, effective July 1, 2026. Mr. Escoe, age 51, is the Executive Vice President of Specialty Products at Illinois Tool Works Inc. and will receive standard non-management director compensation consisting of annual cash and equity retainers. No negative or flat performance metrics are present in this filing.

  • · Kenneth Escoe has served in roles of increasing responsibility with Illinois Tool Works Inc. since 2014.
  • · The Board determined Mr. Escoe qualifies as an independent director under NYSE corporate responsibility standards.
  • · Compensation details for non-management directors are described in the company’s definitive proxy statement filed on April 8, 2026.
  • · Ingredion will enter into its standard form of director indemnification agreement with Mr. Escoe.
BeOne Medicines Ltd. 8-K mixed materiality 6/10

11-06-2026

BeOne Medicines Ltd. held its 2026 Annual General Meeting on June 11, 2026, where shareholders approved all 20 proposals, including the re-election of directors, the appointment of auditors, and the adoption of amended equity incentive plans. Four directors (Michael Goller, Ranjeev Krishana, Corazon D. Sanders, and Qingqing Yi) did not stand for re-election and their terms ended, with no disagreement cited. The meeting saw 73.36% of outstanding shares represented, but notable opposition emerged on several key votes, including the re-election of Dr. Alessandro Riva (with 320 million votes against, or 31.2% of votes cast) and the Connected Person Placing Authorization (which passed with only 42.3% of shares voted in favor, the lowest approval rate).

  • · The General Mandate to Issue Shares passed with 719,798,378 votes for and 308,382,843 against (30.0% opposed).
  • · The General Mandate to Repurchase Shares passed with 1,027,638,828 votes for and only 562,594 against (0.05% opposed).
  • · The advisory vote on Named Executive Officer compensation for FY2025 passed with 975,327,100 for and 52,877,460 against (5.1% opposed).
  • · The discharge of the Board of Directors and Executive Management Team from liability passed with 816,696,880 for and 2,683,088 against, but had 177,864,348 abstentions (17.4% of votes cast).
  • · The proposal to adjourn the meeting if needed passed with 761,069,153 for and 299,855,418 against (28.3% opposed).
CPI AEROSTRUCTURES INC 8-K neutral materiality 3/10

11-06-2026

On June 8, 2026, the Compensation and Human Resources Committee of CPI Aerostructures, Inc. approved salary increases for two top executives. CEO and President Dorith Hakim's annual base salary was raised from $405,000 to $425,000 effective May 1, 2026, while CFO and Secretary Robert Mannix's salary was increased from $300,000 to $325,000 effective July 1, 2026. The filing does not provide any financial results or performance metrics, so no period-over-period comparisons are available.

  • · The salary increases were approved by the Compensation and Human Resources Committee of the Board of Directors.
  • · CEO salary increase effective May 1, 2026; CFO salary increase effective July 1, 2026.
  • · The filing is an 8-K dated June 11, 2026, reporting events from June 8, 2026.
Alphatec Holdings, Inc. 8-K mixed materiality 6/10

11-06-2026

Alphatec Holdings, Inc. held its 2026 annual meeting on June 10, 2026, where stockholders approved the 2026 Equity Incentive Plan and 2026 Employee Stock Purchase Plan, and ratified Deloitte & Touche LLP as auditor. All seven director nominees were elected, with Karen K. McGinnis receiving the highest support (98.4% of votes cast) and Quentin Blackford the lowest (71.1%). The say-on-pay proposal passed with 86.8% support, but the 2026 Equity Incentive Plan received only 70.2% approval, indicating some shareholder dissent.

  • · The 2026 Equity Incentive Plan received 66,250,952 votes for, 28,116,490 against, and 273,648 abstentions, with 23,732,518 broker non-votes.
  • · The 2026 Employee Stock Purchase Plan received 94,532,324 votes for, 85,516 against, and 23,250 abstentions.
  • · Say-on-pay proposal received 81,927,395 votes for, 12,420,476 against, and 293,219 abstentions.
  • · Ratification of Deloitte & Touche LLP received 118,309,646 votes for, 48,208 against, and 15,754 abstentions.
  • · All director nominees were elected; broker non-votes were 23,732,518 for each nominee.
REED'S, INC. 8-K neutral materiality 5/10

11-06-2026

Reed's, Inc. held its 2026 annual meeting on June 10, 2026, where stockholders approved the 2026 Equity Incentive Plan, ratified the appointment of Weinberg & Company P.A. as independent auditor, and elected all five director nominees. The board also determined, consistent with the stockholder vote, that future advisory votes on executive compensation will be held every three years.

  • · The 2026 Equity Incentive Plan was adopted by the Board on March 31, 2026, and became effective upon stockholder approval at the Annual Meeting.
  • · All five director nominees were elected with over 7 million votes each and minimal withhold votes (less than 6,000).
  • · The ratification of Weinberg & Company P.A. as independent auditor passed overwhelmingly with 8,099,074 votes for and only 10,794 against.
  • · The advisory vote on executive compensation passed with 7,068,913 votes for and 5,756 against.
  • · Stockholders voted for a three-year frequency for future advisory votes on executive compensation (6,893,600 votes for three years vs. 176,660 for one year).
  • · The Board determined that future advisory votes on named executive officer compensation will be held every three years until the next required frequency vote.
Acadian Asset Management Inc. 8-K positive materiality 5/10

11-06-2026

Acadian Asset Management Inc. held its 2026 Annual Meeting on June 11, 2026, where stockholders approved the 2026 Equity Incentive Plan, ratified KPMG LLP as independent auditor, and elected five directors. All proposals passed with strong support, though director Andrew Kim received a notable 15.0% vote against (4,681,683 votes), indicating some shareholder dissent.

  • · The 2026 Equity Incentive Plan replaces prior equity plans; no further awards will be granted under the Acadian Asset Management Inc. Equity Incentive Plan or the Non-Employee Directors’ Equity Incentive Plan.
  • · Director Andrew Kim received 4,681,683 votes against (15.0% of votes cast), the highest dissent among nominees.
  • · Ratification of KPMG LLP passed with 32,652,720 votes for and only 50,882 against (0.2% dissent).
  • · Advisory vote on executive compensation passed with 30,451,294 votes for and 752,021 against (2.4% dissent).
  • · The 2026 Plan was approved with 30,544,632 votes for and 672,038 against (2.2% dissent).
PennyMac Financial Services, Inc. 8-K positive materiality 5/10

11-06-2026

PennyMac Financial Services, Inc. (PFSI) announced the appointment of Tiffany To, enterprise AI expert and CEO/Co-Founder of Ontollo, to its Board of Directors, effective June 9, 2026. Ms. To brings deep experience in AI, business transformation, and scaling technology platforms, which aligns with PFSI's tech-first mortgage strategy. The company reported strong operational metrics for the twelve months ended March 31, 2026, with $154 billion in new loan production and $720 billion in loans serviced, employing approximately 5,300 people.

  • · Tiffany To holds a Bachelor of Science in Computer Systems Engineering from Stanford University and an MBA from UC Berkeley Haas School of Business.
  • · Prior to Ontollo, she was EVP and GM of Enterprise & Platform at Atlassian, leading AI-driven knowledge work systems for 300,000 customers.
  • · She served as COO and Board Member at ForAllSecure, building go-to-market strategy for cybersecurity products for the Department of Defense and aerospace/automotive/high-tech clients.
  • · PFSI was founded in 2008 and is recognized as a leader in the U.S. residential mortgage industry.
Legence Corp. 8-K mixed materiality 6/10

11-06-2026

At its 2026 Annual Meeting on June 11, 2026, Legence Corp. stockholders approved all five proposals, including the election of Class I directors David Coghlan and Bilal Khan, the advisory say-on-pay vote, a one-year frequency for future advisory votes, the 2026 Employee Stock Purchase Plan (authorizing up to 1,580,053 shares), and the ratification of Deloitte & Touche as independent auditor for fiscal 2026. Notably, Bilal Khan received a significant 21.0 million withhold votes (21.4% of votes cast), indicating notable shareholder dissent, while David Coghlan was elected with only 1.5 million withheld.

  • · Bilal Khan received 21,021,430 withhold votes (21.4% of votes cast), a significant level of dissent, while David Coghlan received only 1,481,954 withhold votes.
  • · The say-on-pay proposal passed with 95,847,463 FOR votes (97.6% of votes cast), indicating strong shareholder support for NEO compensation.
  • · The one-year frequency for future advisory votes on NEO compensation was approved with 97,839,229 FOR votes (97.6% of votes cast).
  • · The ESPP was approved with 98,024,042 FOR votes (99.99% of votes cast), with only 4,856 AGAINST.
  • · Ratification of Deloitte & Touche as independent auditor for FY2026 passed with 100,320,150 FOR votes (99.98% of votes cast).
  • · The company determined to hold an advisory vote on NEO compensation every one year until the next stockholder vote on frequency.
Marvell Technology, Inc. 8-K positive materiality 6/10

11-06-2026

Marvell Technology announced the appointment of Dan Durn as CFO effective June 15, 2026, succeeding Willem Meintjes, who will remain in an advisory capacity through April 2027. Durn brings over 30 years of semiconductor and enterprise technology financial leadership, having previously served as CFO at Adobe, Applied Materials, NXP, Freescale, and GlobalFoundries. The company also reaffirmed its Q2 fiscal 2027 financial outlook provided on May 27, 2026, indicating no change in expectations.

  • · Dan Durn resigned from Marvell's Board of Directors effective June 10, 2026, prior to his CFO appointment.
  • · Willem Meintjes will remain available in an advisory capacity through April 2027.
  • · Durn holds an MBA in Finance from Columbia Business School and a BS in Control Systems Engineering from the U.S. Naval Academy, and served as a naval officer for six years.
  • · The company reaffirmed its Q2 fiscal 2027 financial outlook as provided on May 27, 2026.
Pacira BioSciences, Inc. 8-K neutral materiality 4/10

11-06-2026

Pacira BioSciences announced that at its 2026 Annual Meeting of Stockholders, all three of the company's director nominees—Christopher Christie, Samit Hirawat, MD, and Thomas Wiggans—were elected to the Board of Directors based on preliminary results. CEO Frank D. Lee expressed gratitude for stockholder trust and reaffirmed the company's commitment to its 5x30 strategy. The filing does not include any financial results or performance metrics, so no positive or negative financial trends are reported.

  • · Pacira's commercial-stage non-opioid treatments include EXPAREL, ZILRETTA, and iovera°.
  • · The company's most advanced pipeline candidate, PCRX-201, is in Phase 2 clinical development for osteoarthritis of the knee.
  • · Goldman Sachs & Co. LLC acted as financial advisor and Perkins Coie LLP as legal counsel to Pacira.
  • · Final election results will be tabulated by an independent inspector and reported in a subsequent Form 8-K.
Weatherford International plc 8-K mixed materiality 8/10

11-06-2026

Weatherford International plc held its 2026 Annual General Meeting and Special Court-Convened Meeting on June 11, 2026. While shareholders approved all annual business items, including the election of directors and the Fifth Amended and Restated 2019 Equity Incentive Plan, the proposed redomestication from Ireland to the United States (Texas) failed to receive the required 75% shareholder support on several key proposals, despite receiving over 60% of votes cast. The company stated that redomestication remains a priority and intends to present an updated proposal to redomesticate to Delaware at a future meeting.

  • · The Fifth Amended and Restated 2019 Equity Incentive Plan was approved by shareholders, increasing the share reserve by 565,000 ordinary shares.
  • · All six director nominees were elected, with support ranging from approximately 52.96 million votes (Neal P. Goldman) to 64.68 million votes (Girishchandra K. Saligram).
  • · The non-binding advisory vote on executive compensation (Say-on-Pay) passed with approximately 64.08 million For votes.
  • · Ratification of KPMG as auditor passed with approximately 66.73 million For votes.
  • · Authority to issue shares and opt-out of preemption rights under Irish law were approved.
  • · The company intends to file a registration statement on Form S-8 to register the additional shares under the equity plan.
  • · The redomestication proposals failed to reach the 75% threshold, with support ranging from approximately 61% to 66% of votes cast (excluding broker non-votes).
VERACYTE, INC. 8-K mixed materiality 6/10

11-06-2026

Veracyte, Inc. held its 2026 Annual Meeting on June 10, 2026, where stockholders elected all nine director nominees, ratified Ernst & Young as independent auditor, approved executive compensation on an advisory basis, and approved an amendment to the 2023 Equity Incentive Plan to increase authorized shares by 3,500,000. The amendment to the equity plan received the lowest support among proposals, with 52,059,077 votes for and 21,060,296 against, indicating notable shareholder dissent.

  • · The 2023 Plan Amendment was approved by the Board on April 8, 2026, subject to stockholder approval.
  • · Broker non-votes totaled 2,700,490 on all proposals except the auditor ratification (which had no broker non-votes).
  • · Director Robert S. Epstein received the lowest for votes among nominees (67,973,349) with 5,078,388 against.
  • · The auditor ratification received the highest support: 75,452,164 for, 379,788 against, 37,748 abstain.
  • · The advisory vote on executive compensation passed with 71,266,771 for and 1,858,805 against.
Inogen Inc 8-K mixed materiality 6/10

11-06-2026

Inogen Inc. held its 2026 Annual Meeting on June 5, 2026, with 76.28% of outstanding shares represented. Stockholders approved the Amended and Restated 2023 Equity Incentive Plan (adding 750,000 shares), ratified Deloitte & Touche LLP as auditor, and approved executive compensation on an advisory basis. However, the proposal to declassify the Board was not approved, and director Mira Sahney received a significant 27.4% withhold vote (4,996,396 votes withheld), indicating notable shareholder dissent.

  • · The proposal to declassify the Board was not approved, with 17,883,761 votes for and 154,379 against, but 235,085 abstentions and 2,571,716 broker non-votes.
  • · Director Mira Sahney received 4,996,396 votes withheld (27.4% of votes cast), a significant level of dissent.
  • · The Amended and Restated 2023 Equity Incentive Plan adds 750,000 shares of common stock.
  • · The record date for the Annual Meeting was April 6, 2026.
Arq, Inc. 8-K mixed materiality 6/10

11-06-2026

At its 2026 Annual Meeting on June 10, 2026, Arq, Inc. stockholders approved the 2026 Omnibus Incentive Plan authorizing up to 1,500,000 shares plus certain carryover shares, and elected six directors. The advisory vote on executive compensation passed with 21.6M votes for, while the 2026 Plan approval received 16.5M for and 3.9M against, with 9.6M broker non-votes. The ratification of Baker Tilly as auditor passed overwhelmingly with 31.9M votes for.

  • · The 2026 Omnibus Incentive Plan allows grants of options, stock appreciation rights, restricted stock, RSUs, performance share units, and other stock-based and cash-based awards to employees, directors, and consultants.
  • · The Ninth Amendment to Tax Asset Protection Plan was approved with 20.8M votes for, 1.5M against, and 23.9K abstentions.
  • · All six director nominees were elected; Jeremy Blank received the lowest 'for' votes (19.8M) and Julian McIntyre the highest 'withheld' votes (2.7M).
  • · The advisory vote on executive compensation (Say-on-Pay) passed with 21.6M for, 670K against, and 129.5K abstentions.
  • · The ratification of Baker Tilly as auditor had 31.9M for, 58.9K against, and 74.5K abstentions, with no broker non-votes.
Fulcrum Therapeutics, Inc. 8-K negative materiality 8/10

11-06-2026

Fulcrum Therapeutics announced cash retention payments totaling $370,040 to CEO Alex Sapir, $195,480 to Chief Legal Officer Curtis Oltmans, and $195,200 to CFO Alan Musso, along with enhanced Change in Control benefits for VP-level employees, following a restructuring plan approved May 31, 2026, after discontinuing pociredir for sickle cell disease. Additionally, VP of Finance and principal accounting officer Greg Tourangeau mutually agreed to depart on a future date, with no disagreement over financial matters. The restructuring reflects significant downsizing to nine remaining full-time employees, indicating a severe reduction in workforce and operational scope.

  • · Restructuring plan approved May 31, 2026, following discontinuation of pociredir development for sickle cell disease.
  • · Retention payments are payable upon earlier of Change in Control or termination without Cause, subject to satisfaction of transitional duties.
  • · Enhanced Change in Control benefits provided for VP-level and above employees if terminated without Cause within six months prior to a Change in Control.
  • · Employment agreements for Sapir, Oltmans, and Musso were amended effective June 5 and June 11, 2026, respectively.
  • · Greg Tourangeau's departure is not due to any disagreement over financial statements, accounting policies, internal controls, or disclosure controls.
FARMERS & MERCHANTS BANCORP 8-K positive materiality 5/10

11-06-2026

Farmers & Merchants Bancorp (FMCB) appointed Jehna Silva to its Board of Directors effective June 8, 2026. Ms. Silva brings over 15 years of commercial banking experience and will serve on the CRA, Budget and Finance, and ALCO Committees. The company highlighted its strong financial position with $5.8 billion in assets, a 5-Star rating from BauerFinancial for 35 consecutive years, and a 91-year dividend payment history, including 61 consecutive years of increases, ranking 17th among Dividend Kings.

  • · F&M Bank was ranked 5th on Forbes' 'America’s Best Banks' list for 2025 and 1st in California.
  • · In July 2025, FMCB was named #3 best-performing bank in the nation by Bank Director’s Magazine (2024 study).
  • · F&M Bank was ranked 20th largest bank lender to agriculture in the US as of December 31, 2025.
  • · The FDIC awarded F&M Bank an 'Outstanding' CRA rating in its last evaluation.
  • · FMCB has paid dividends for 91 consecutive years and increased dividends for 61 consecutive years.
GRAPHIC PACKAGING HOLDING CO 8-K neutral materiality 3/10

11-06-2026

Graphic Packaging Holding Company (GPK) announced the election of Larry M. Venturelli as Chairman of the Board, effective June 11, 2026, succeeding Philip R. Martens who is retiring after serving as a director since 2013 and Chairman since 2016. The filing contains no financial data or performance metrics, only a leadership transition.

  • · Larry Venturelli has been a board member since 2016 and served on Nominating and Corporate Governance, Audit, and Compensation and Management Development Committees.
  • · Philip Martens served as Chairman since May 2016 and as a director since November 2013.
  • · Larry Venturelli previously served as Executive Vice President and CFO at Whirlpool Corporation.
ADAMAS TRUST, INC. 8-K neutral materiality 5/10

11-06-2026

Adamas Trust, Inc. declared a regular quarterly cash dividend of $0.27 per share on its common stock for the quarter ending June 30, 2026, payable on July 28, 2026 to stockholders of record as of June 23, 2026. The Board also declared cash dividends on its Series D, E, F, and G preferred stocks, with per-share amounts ranging from $0.4296875 to $0.6549289, payable on July 15, 2026. The filing does not provide prior-period dividend comparisons, so no period-over-period performance metrics are available.

  • · The common stock dividend record date is June 23, 2026, and payment date is July 28, 2026.
  • · Preferred stock dividends cover the period from April 15, 2026 to July 14, 2026, with a record date of July 1, 2026 and payment date of July 15, 2026.
  • · The preferred stock series have fixed-to-floating rates (Series D, E, F) or fixed rate (Series G), with stated coupon rates: 8.000% (Series D), 7.875% (Series E), 6.875% (Series F), and 7.000% (Series G).
MURPHY OIL CORP 8-K neutral materiality 4/10

11-06-2026

Murphy Oil Corporation announced the immediate retirement of E. Ted Botner as Executive Vice President, General Counsel and Corporate Secretary, effective June 11, 2026, with his full retirement from the company on June 30, 2026. Roger W. Landes, Associate General Counsel, has been appointed Interim General Counsel and Corporate Secretary. No financial figures or period-over-period comparisons are included in this filing.

  • · E. Ted Botner's retirement as Executive Vice President, General Counsel and Corporate Secretary is effective immediately as of June 11, 2026.
  • · Botner will fully retire from the company on June 30, 2026.
  • · Roger W. Landes was previously Associate General Counsel before being appointed Interim General Counsel and Corporate Secretary.
IDT CORP 8-K neutral materiality 4/10

11-06-2026

IDT Corp announced the resignation of director Irwin Katsof on June 9, 2026, effective immediately, with no disagreement related to the company's operations. The board appointed William Conkling as a new independent director, effective the same day, to serve as Audit Committee Chairman and Financial Expert, as well as on the Compensation and Corporate Governance Committees. Conkling brings extensive pharmaceutical and commercialization experience, including roles at Protara Therapeutics, Rafael Holdings, and Novartis.

  • · William Conkling's term will expire at the 2026 annual meeting of stockholders.
  • · Conkling is eligible to participate in the Company’s Non-Employee Director Compensation Program, which includes cash and equity-based awards.
  • · Conkling served as CEO of Rafael Holdings from February 2022 to May 2025.
  • · Conkling helped lead product commercialization for Immunomedics Inc., which was acquired by Gilead for $21 billion in October 2020.
  • · Conkling holds a Bachelor’s Degree from Fordham University and an MBA from NYU Stern School of Business.
StageWise Strategies Corp. 8-K neutral materiality 9/10

11-06-2026

On June 5, 2026, Jakhongir Abidovich Artikkhodjaev acquired a 74.2% controlling interest in StageWise Strategies Corp. for $750,000 in cash, purchasing 3,000,000 shares from former majority holders Viktor Balan and Yuliia Zaporozhan. In connection with the change of control, all prior directors and officers resigned, and a new management team was appointed, including Elmurod Sopiev as CEO and Temur Zokirov as CFO, Secretary, and Chairman of the Board. The new leadership is closely tied to Tourism and Entertainment Group, LLC (TEG), a Uzbekistan-based hospitality company, signaling a strategic pivot toward the hospitality sector.

  • · The company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.
  • · The company's principal executive office is located in Tashkent, Republic of Uzbekistan, c/o Tourism and Entertainment Group, LLC.
  • · The company's common stock is not registered on any national securities exchange (trading symbol N/A).
  • · New CEO Elmurod Sopiev previously served as General Manager of Hilton Tashkent City and Director of AKFA Dream World, both TEG subsidiaries.
  • · New CFO Temur Zokirov previously worked at PricewaterhouseCoopers in Tashkent as a Manager and tax consultant.
  • · New independent director Bahtiyor Kadirov previously served as Senior Audit Manager at Ernst & Young's Tashkent office.
  • · New independent director Elina Davidyan has served as Finance Director of East Restaurant and Chief Accountant of AFKA Dream World since July 2020.
  • · There are no family relationships or reportable transactions under Item 404(a) among the new officers and directors.
PALISADE BIO, INC. 8-K neutral materiality 5/10

11-06-2026

Palisade Bio, Inc. filed an 8-K on June 11, 2026, announcing amendments to its Amended and Restated Certificate of Incorporation, approved by the Board of Directors and stockholders. The amendment increases authorized Common Stock from an unspecified prior amount to 450,000,000 shares (par value $0.01 per share) and authorized Preferred Stock to 7,000,000 shares (par value $0.01 per share). The filing also covers director/officer changes (Items 5.02, 5.03, 5.07) but no specific departures or elections are detailed in the provided content.

  • · Original incorporation date: February 28, 2001, under the name 'Neuralstem, Inc.'
  • · Common Stock par value: $0.01 per share
  • · Preferred Stock par value: $0.01 per share
  • · Each share of Common Stock entitles holder to one vote per matter
  • · Board of Directors authorized to fix designations, powers, preferences, and rights of Preferred Stock series
  • · Board may increase or decrease number of shares of any Preferred Stock series (subject to limits)
DENTSPLY SIRONA Inc. 8-K neutral materiality 6/10

11-06-2026

DENTSPLY SIRONA Inc. (XRAY) announced the appointment of John Fortson as Executive Vice President and Chief Financial Officer, effective July 20, 2026. Fortson brings over 25 years of experience, including CFO and CEO roles at Kymera International and Ingevity Corporation, and a track record of capital deployment, transformation, and growth initiatives. The filing does not disclose any financial results or performance metrics, so no period-over-period comparisons are available.

  • · Fortson's appointment is effective July 20, 2026.
  • · He previously served as President and CFO of Kymera International, a specialty materials company backed by Palladium Equity Partners and Goldman Sachs.
  • · At Ingevity, he led the separation from WestRock, built finance, treasury, tax, investor relations, internal audit, and IT capabilities, and established a capital structure including a $700M credit facility and $300M high-yield bond offering.
  • · At AAR Corp., he led a portfolio transformation that included divesting non-core manufacturing assets, retiring $325M of debt, and returning over $150M to shareholders via share repurchases.
  • · Fortson holds an MBA from Duke University's Fuqua School of Business and a BS from the United States Military Academy at West Point.
Alaska Silver Corp. 8-K neutral materiality 6/10

11-06-2026

Alaska Silver Corp. announced the appointment of Aaron Schutt as CEO effective October 1, 2026, succeeding co-founder Kit Marrs, who will become Executive Chairman. Schutt brings extensive Alaska-based leadership experience, having recently retired as President and CEO of Doyon Limited, a $500M+ revenue enterprise. The transition marks a leadership change but maintains continuity with Marrs remaining on the board.

  • · Aaron Schutt holds a B.S. in civil engineering from Washington State University, an M.S. in civil engineering from Stanford, and a J.D. from Stanford Law School.
  • · Kit Marrs co-founded Western Alaska Copper & Gold Co. with his wife Joan in 2010.
  • · Alaska Silver listed on TSX Venture Exchange in 2021 and on OTCQX in 2025.
  • · The Illinois Creek Project is 100% owned and contiguous, totaling 80,895 acres.
  • · Waterpump Creek zone hosts an Inferred Mineral Resource of 75 Moz AgEq at 279 g/t silver, 11.28% zinc, and 9.87% lead.
  • · Illinois Creek Mine has Indicated Resources of 260,000 oz gold at 0.92 g/t Au and 8.3 Moz silver at 29.72 g/t Ag, plus Inferred Resources of 290,000 oz gold at 0.84 g/t Au and 10.4 Moz silver at 30.11 g/t Ag.
  • · The project is located 38 km from the Yukon River, a primary marine transportation corridor.
REGENEREX PHARMA, INC. 8-K negative materiality 9/10

11-06-2026

Regenerex Pharma, Inc. has filed a lawsuit against its former CFO, Kenneth W. Perry, alleging unauthorized payroll overpayments of approximately $55,200, self-dealing through a company he owned (Optimize Health Partners, LLC) resulting in overcharges of about $37,285, unauthorized issuance of 25,000 shares of company stock, and destruction of financial records that impaired the company's year-end audit and delayed its Form 10-K filing. The company also alleges extortionate conduct by Perry in demanding a separation agreement under threat of harm. The filing highlights significant internal control failures and potential regulatory exposure, but the company had maintained an uninterrupted 20-year history of timely SEC filings prior to this incident.

  • · Mr. Perry began employment as CFO on March 31, 2025.
  • · The unauthorized payroll overpayments occurred over at least 6 months.
  • · The agreement with Optimize Health Partners was entered on September 23, 2025, for a five-year term.
  • · Mr. Perry allegedly made false statements to government agencies, auditors, and investment bankers.
  • · The company's investigation remains ongoing and additional irregularities may exist.
Elvictor Group, Inc. 8-K positive materiality 5/10

11-06-2026

Elvictor Group, Inc. appointed Theocharis Vasilakis as Chief Technology Officer to lead its AI-powered crew management platform development and digital infrastructure modernization. The company is accelerating investments in AI and automation, with an MVP targeted for Q4 2026 and broader deployment anticipated in 2027. However, the filing contains no financial metrics or period-over-period comparisons, and forward-looking statements caution that actual results may differ materially from expectations.

  • · Development of the technology initiative commenced in February 2026.
  • · Initial platform deployment (MVP) targeted for Q4 2026; broader deployment anticipated in 2027.
  • · Mr. Vasilakis is a co-founder of Hermetica, an AI-native intelligence platform, and has held software engineering roles with European Dynamics and OpenBet Hellas.
  • · The company is an OTC-traded issuer (OTCID: ELVG) providing maritime crew management and recruitment services.
  • · Forward-looking statements include expectations for cost reductions from planned staff retirements beginning in Q3 2026 and discussions with prospective clients in tanker and bulk carrier segments.
Eightco Holdings Inc. 8-K positive materiality 8/10

11-06-2026

Eightco Holdings Inc. (ORBS) disclosed total treasury holdings of approximately $406 million as of June 10, 2026, including $90 million indirect OpenAI equity, $18 million Beast Industries equity, 283 million WLD tokens, 16,278 ETH, and $142 million cash/stablecoins. The company highlighted its unique exposure to AI, digital identity, and the creator economy, and noted OpenAI's confidential S-1 filing for a potential IPO. However, the filing does not provide any period-over-period comparisons, so trends in holdings or performance cannot be assessed.

  • · Eightco holds 283,452,700 WLD tokens, approximately 8.4% of circulating supply, the largest publicly disclosed institutional position globally.
  • · World identifies a $6.35 trillion combined addressable revenue opportunity across 13 industries.
  • · ChatGPT crossed 900 million weekly active users in February 2026.
  • · Beast Industries has a combined 500 million-plus follower base across platforms, anchored by MrBeast.
  • · The filing does not include any period-over-period comparisons, so trends in holdings or performance cannot be assessed.
DUKE Robotics Corp. 8-K positive materiality 8/10

11-06-2026

Duke Robotics Corp. (Nasdaq: DUKR) announced the appointment of Yiftach Kleinman as CEO, effective no later than September 8, 2026. Current CEO Yossef Balucka will remain as President, focusing on commercial business. Mr. Kleinman brings over 20 years of defense leadership experience, including leading Israeli loitering-munitions firm SpearUAV through its 2025 acquisition by UVision, and senior roles at Rafael Advanced Defense Systems. The change comes as Duke Robotics looks to significantly expand its defense business following its recent Nasdaq uplisting.

  • · Mr. Kleinman's appointment is effective upon commencement of employment, expected no later than September 8, 2026.
  • · Prior to SpearUAV, Mr. Kleinman spent over a decade at Rafael Advanced Defense Systems, where he served as Deputy General Manager for Subsidiaries, M&A, and initiated Rafael's largest acquisition ever in a NATO country.
  • · Mr. Kleinman previously served as a Colonel in the Israel Defense Forces (active reserve).
  • · The transition follows Duke Robotics' recent uplisting to the Nasdaq Capital Market.
  • · Duke Robotics holds a collaboration agreement with Elbit Systems Land Ltd. for the Bird of Prey weapons drone system.
LVPAI GROUP Ltd 8-K neutral materiality 6/10

11-06-2026

LVPAI GROUP Ltd announced a broad management and board reshuffle effective June 9, 2026. CEO Chen Yuanhang stepped down (remaining on the board), and CFO Wei Zurui departed entirely, while Zhao Ling (new CEO), Zhang Wenmin (new CFO), Yang Fuzhu (Chairman), and four new independent directors (Zhu Chen, Liang Wu, Chen Wenqing, Ge Sihua) were appointed.

  • · CEO Chen Yuanhang stepped down but continues as a board member.
  • · CFO Wei Zurui resigned from both CFO and board positions.
  • · Zhao Ling appointed as new CEO and director.
  • · Zhang Wenmin appointed as new CFO.
  • · Yang Fuzhu appointed as Chairman of the Board.
  • · Four new independent directors appointed: Zhu Chen, Liang Wu, Chen Wenqing, Ge Sihua.
  • · All changes effective June 9, 2026 at 12:00 pm.
CAMDEN PROPERTY TRUST 8-K neutral materiality 3/10

11-06-2026

Camden Property Trust announced the retirement of Michael P. Gallagher, Senior Vice President – Chief Accounting Officer, effective July 2, 2026, and the appointment of Kevin J. Necas, Jr. as his successor. Necas, who joined the company in 2023 and was promoted to Vice President-Accounting in 2024, will assume the role of Senior Vice President – Chief Accounting Officer and principal accounting officer on the same date. No financial metrics or performance data were disclosed in this filing.

  • · Kevin J. Necas, Jr. is a certified public accountant with a Master of Accountancy and B.B.A. in Finance and Legal Studies from Tulane University.
  • · Necas's prior five-year experience includes roles at CenterPoint Energy and Phillips 66.
  • · No arrangements or understandings exist between Necas and any other persons regarding his appointment.
  • · Necas has no family relationships requiring disclosure under Item 401(d) of Regulation S-K and no material interest in any transaction required to be disclosed under Item 404(a) of Regulation S-K.
Nukkleus Inc. 8-K neutral materiality 4/10

11-06-2026

T3 Defense Inc. (formerly Nukkleus Inc.) appointed Roy Cohen as Chief Financial Officer effective June 1, 2026. Mr. Cohen brings over 25 years of financial leadership experience, including serving as Global Chief Controller at NASDAQ-listed Orbotech Ltd. (over $1B revenue). He will receive NIS 55,000 per month until September 2026, increasing to NIS 65,000 per month thereafter.

  • · Mr. Cohen served as Senior Financial Consultant from 2023 to present, CFO of Pangaya Ltd. from 2022 to 2023, and VP Finance and Chief Controller of Cintec Media Ltd. from 2020 to 2022.
  • · He is a Certified Public Accountant and holds a B.A. in Business Administration (Accounting and Finance) from the College of Management Academic Studies.
  • · Mr. Cohen has no familial relationships with previous directors or executive officers, and no reportable transactions with the company in the last two years.
  • · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.
TELA Bio, Inc. 8-K mixed materiality 6/10

11-06-2026

TELA Bio, Inc. held its 2026 Annual Meeting on June 9, 2026, where stockholders approved an amendment to the Amended and Restated 2019 Equity Incentive Plan, increasing authorized shares by 3,500,000. All three Class I director nominees (Joseph Capper, Betty Jo Rocchio, William Plovanic) were elected, and KPMG LLP was ratified as independent auditor for fiscal 2026. However, the non-binding advisory vote on executive compensation received only 75.2% support, with 24.8% of votes cast against, indicating notable shareholder dissent.

  • · The Plan Amendment became effective immediately upon stockholder approval at the Annual Meeting.
  • · The non-binding advisory vote on executive compensation had 6,900,032 votes against and 19,962 abstentions, representing 24.8% of votes cast against.
  • · KPMG LLP was ratified with 33,443,686 votes for, 17,890 against, and 622 abstentions.
  • · All three Class I director nominees were elected with over 27 million votes each.
  • · The Plan Amendment was approved with 27,256,266 votes for, 538,830 against, and 16,593 abstentions.
Elvictor Group, Inc. 8-K negative materiality 6/10

11-06-2026

Elvictor Group, Inc. removed Christodoulos Tzoutzakis as Chief Operating Officer and Chief Technology Officer effective June 11, 2026. The removal was without cause and not related to any disagreement with the Board or management, nor to any matter involving the Company's operations, financial reporting, or internal controls.

  • · The removal was effective June 11, 2026.
  • · Mr. Tzoutzakis held dual roles as COO and CTO.
  • · The filing states the removal was not for cause and not due to any disagreement with the Board or management.
  • · No replacement for the departed officer was announced in this filing.
BRADY CORP 8-K mixed materiality 8/10

11-06-2026

Brady Corporation announced the retirement of CEO Russell Shaller after an 11-year tenure and the appointment of current board member Vineet Nargolwala as his successor, effective June 8, 2026. Shaller will remain in a consultative role until August 1, 2026. The transition is tied to the company's pending acquisition of Honeywell's Productivity Solutions and Services (PSS) business, which Nargolwala was involved in evaluating as a board member.

  • · Vineet Nargolwala previously served as President, CEO and Director of Allegro MicroSystems from June 2022 to February 2025.
  • · Nargolwala spent nearly a decade at Sensata Technologies and earlier nearly 10 years at Honeywell in senior leadership roles.
  • · Shaller achieved five consecutive years of both organic sales growth and record EPS.
  • · The company's fiscal 2025 sales were approximately $1.51 billion.
  • · Brady employed approximately 6,400 people as of July 31, 2025.

Get daily alerts with 10 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Corporate Board Director Changes SEC Filings

🇺🇸 More from United States

View all →